TR201914420A2 - Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar - Google Patents

Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar Download PDF

Info

Publication number
TR201914420A2
TR201914420A2 TR2019/14420A TR201914420A TR201914420A2 TR 201914420 A2 TR201914420 A2 TR 201914420A2 TR 2019/14420 A TR2019/14420 A TR 2019/14420A TR 201914420 A TR201914420 A TR 201914420A TR 201914420 A2 TR201914420 A2 TR 201914420A2
Authority
TR
Turkey
Prior art keywords
antioxidant
pharmaceutical formulations
formulations containing
sapropterin dihydrochloride
containing sapropterin
Prior art date
Application number
TR2019/14420A
Other languages
English (en)
Inventor
Türkoğlu Damla
Palantöken Arzu
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/14420A priority Critical patent/TR201914420A2/tr
Priority to EP20868726.9A priority patent/EP4034126A4/en
Priority to PCT/TR2020/050690 priority patent/WO2021061067A1/en
Publication of TR201914420A2 publication Critical patent/TR201914420A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Abstract

Mevcut buluş, sapropterin dihidroklorür ve en az bir antioksidan içeren farmasötik formülasyonlarla ilgilidir.
TR2019/14420A 2019-09-23 2019-09-23 Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar TR201914420A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/14420A TR201914420A2 (tr) 2019-09-23 2019-09-23 Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar
EP20868726.9A EP4034126A4 (en) 2019-09-23 2020-08-05 PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN HYDROCHLORIDE AND AT LEAST ONE ANTIOXIDANT
PCT/TR2020/050690 WO2021061067A1 (en) 2019-09-23 2020-08-05 Pharmaceutical formulations comprising sapropterin dihydrochloride and at least one antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/14420A TR201914420A2 (tr) 2019-09-23 2019-09-23 Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar

Publications (1)

Publication Number Publication Date
TR201914420A2 true TR201914420A2 (tr) 2021-04-21

Family

ID=75167041

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/14420A TR201914420A2 (tr) 2019-09-23 2019-09-23 Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar

Country Status (3)

Country Link
EP (1) EP4034126A4 (tr)
TR (1) TR201914420A2 (tr)
WO (1) WO2021061067A1 (tr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845952A2 (en) * 2004-11-17 2007-10-24 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CA2828685C (en) * 2011-03-01 2018-05-29 Rubicon Research Private Limited Stable compositions of tetrahydrobiopterin
US9216178B2 (en) * 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN104257623A (zh) * 2014-09-09 2015-01-07 广东中盛药物研究院有限公司 一种含盐酸沙丙蝶呤的泡腾片

Also Published As

Publication number Publication date
EP4034126A4 (en) 2023-10-18
EP4034126A1 (en) 2022-08-03
WO2021061067A1 (en) 2021-04-01

Similar Documents

Publication Publication Date Title
MA43187B1 (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
GEP20237506B (en) Pcsk9 antagonist compounds
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
MD3209310T2 (ro) Compoziții care conțin tulpini bacteriene
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
CL2016003422A1 (es) Inhibidores de demetilasa-1 específico de lisina
CY1122024T1 (el) Ενωσεις αναστολης σηματοδοτησης μονοπατιου notch
MX2019011496A (es) Composiciones de niraparib.
MA45809A (fr) Promédicaments de pth
CL2016003423A1 (es) Inhibidores de demetilasa-1 específico de lisina
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
MX367669B (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos.
EA201892822A1 (ru) Новые антибактериальные соединения
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
EA202090732A1 (ru) Составы для трансдермального введения
TR201901228T4 (tr) Vortioksetin piroglutamat.
MX2021006674A (es) Composiciones para estabilizar bacterias y usos de las mismas.
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
MX2019010330A (es) Formulaciones con mejora de la estabilidad.
EA201791716A1 (ru) Фармацевтический состав
MX2018007231A (es) Una composicion antimicrobiana.
EA202090270A1 (ru) Новые замещенные производные ксантина
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar